These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 22624541)
41. Multiple forms of exploitation in international research: the need for multiple standards of fairness. Snyder J Am J Bioeth; 2010 Jun; 10(6):40-1. PubMed ID: 20526969 [No Abstract] [Full Text] [Related]
42. Explicit declaration of ethical approval for clinical research. Eastwood GM Aust Crit Care; 2011 May; 24(2):89. PubMed ID: 21546261 [No Abstract] [Full Text] [Related]
43. Vulnerability to influence: a two-way street. Henderson GE; Davis AM; King NM Am J Bioeth; 2004; 4(3):50-2; discussion W32. PubMed ID: 16192139 [No Abstract] [Full Text] [Related]
44. The role of controversial research in the IRB's risk/benefit analysis. Lunstroth J Am J Bioeth; 2011 May; 11(5):14-6. PubMed ID: 21534141 [No Abstract] [Full Text] [Related]
45. Action research in public schools: is it research? Should it be reviewed? Sigler E J Empir Res Hum Res Ethics; 2009 Jun; 4(2):17-25. PubMed ID: 19480588 [TBL] [Abstract][Full Text] [Related]
46. Towards a reasons-based pragmatic ethical framework. Viens AM Am J Bioeth; 2008 Apr; 8(4):41-3. PubMed ID: 18576254 [No Abstract] [Full Text] [Related]
47. Justice in the application of science: beyond fair benefits. London AJ Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976 [No Abstract] [Full Text] [Related]
48. Human rights: the normative engine of fairness and research in developing countries. McMillan J Am J Bioeth; 2010 Jun; 10(6):47-9. PubMed ID: 20526973 [No Abstract] [Full Text] [Related]
49. Ethical considerations for research in critically ill patients. Bigatello LM; George E; Hurford WE Crit Care Med; 2003 Mar; 31(3 Suppl):S178-81. PubMed ID: 12626965 [No Abstract] [Full Text] [Related]
50. Pragmatism, principles, and protection. Hester DM; Brown J; Schonfeld T Am J Bioeth; 2008 Apr; 8(4):32-4. PubMed ID: 18576249 [No Abstract] [Full Text] [Related]
51. Module five: implementation of ethics review. Dhai A Dev World Bioeth; 2005 Mar; 5(1):73-91. PubMed ID: 15748179 [TBL] [Abstract][Full Text] [Related]
52. The unintended ethics of Henry K Beecher. Stark L Lancet; 2016 Jun; 387(10036):2374-5. PubMed ID: 27312298 [No Abstract] [Full Text] [Related]
53. Response to open peer commentaries on "Social contexts influence ethical considerations of research". Levine RJ; Gordon JB; Mazure CM; Rubin PE; Schaller BR; Young JL Am J Bioeth; 2011 May; 11(5):W1-2. PubMed ID: 21534134 [No Abstract] [Full Text] [Related]
55. IRBs and the long-term social implications of research. de Melo-Martin I Am J Bioeth; 2011 May; 11(5):22-3. PubMed ID: 21534145 [No Abstract] [Full Text] [Related]
56. The Global Forum for Bioethics in Research: report of a meeting. Loff B; Hofman K; Muthuswamy V Issues Med Ethics; 2001; 9(2):63-4. PubMed ID: 16334477 [No Abstract] [Full Text] [Related]
57. One size does not fit all: toward "upstream ethics"? Ozdemir V; Knoppers BM Am J Bioeth; 2010 Jun; 10(6):42-4. PubMed ID: 20526970 [No Abstract] [Full Text] [Related]
58. Undue inducement: nonsense on stilts? Emanuel EJ Am J Bioeth; 2005; 5(5):9-13; discussion W8-11, W17. PubMed ID: 16179296 [No Abstract] [Full Text] [Related]
59. International research and positive obligations: are they "transaction specific"? Rossi J Am J Bioeth; 2010 Jun; 10(6):49-51. PubMed ID: 20526974 [No Abstract] [Full Text] [Related]
60. [Ethics committees in USA--background and development. Responsible conductors of clinical trials required for risk minimization]. Lund LH Lakartidningen; 2008 Jan 9-15; 105(1-2):42-4. PubMed ID: 18293746 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]